[1]
W. Jiang, “Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC”, Radiol Oncol, vol. 59, no. 4, pp. 617–623, Dec. 2025.